Radiology Solutions
Ensure imaging studies provide insights while minimizing risks
Company profile
Company profile
Evolent is a specialty care management company that partners with health plans to improve clinical outcomes and affordability across multiple medical specialties. The company operates on a fundamental belief that every person deserves the same quality of care they would want for their loved ones. Evolent's comprehensive solutions span oncology, cardiology, musculoskeletal disorders, radiology, genetic testing, physical medicine, and surgical management, serving over 40 million unique members. The company employs a clinical-first approach backed by over 1,300 clinicians including nearly 400 physicians and 750 nurses, supported by five scientific advisory boards comprising noted academic and community-based specialist physicians. These boards ensure that Evolent's high-value clinical pathways reflect the latest evidence and real-world clinical perspectives. The company's technology platforms provide point-of-care decision support tools that guide providers to evidence-based treatment options, with approximately 50% auto-authorization rates for medical oncology regimens. Evolent takes financial and clinical accountability for specialty care through delegated risk agreements, implementing value-based payment models that align incentives across the care continuum. The company's solutions integrate administrative services, care navigation, and clinical management to reduce care fragmentation. With a global workforce of 4,000 employees across the United States, India, and the Philippines, and 350 engineers designing better provider and member experiences, Evolent partners with health plans to transform specialty care delivery and achieve typical increases of 30%+ in adherence to high-value clinical pathways.
Company description Evolent official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Serving 40 million unique members covered by one or more Evolent solutions. Published clinical outcomes in peer-reviewed Journal of Clinical Pathways.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Ensure imaging studies provide insights while minimizing risks
Ensure alignment with treatment and testing guidelines for cardiovascular care
Comprehensive back-, middle- and front-office services for health plans
Personalized support and digital platform for cancer patients
Clinical expertise and peer review for appropriate genetic testing
Provider-centric approach to high-value pain management and surgery
Clinical pathways and decision support for high-value cancer care
Comprehensive management of therapy services
Evidence-based clinical pathways with automatic authorization
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
JSES international · Mar 1, 2026
Breast cancer and the use of predictive genomics.The American journal of managed care · Jun 1, 2025
The dangerous intersection of breast cancer and cardiovascular disease: a call for improved prevention.The American journal of managed care · Dec 1, 2024
Cancer drugs speed to accelerated approvals, then hit the brakes in timely, clinically beneficial confirmatory trials.The American journal of managed care · Aug 1, 2024
Effective care management by Next Generation accountable care organizations.The American journal of managed care · Jul 1, 2020
The bird's-eye view: A data-driven approach to understanding patient journeys from claims data.Journal of the American Medical Informatics Association : JAMIA · Jul 1, 2020
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Typical increase among new health plan partners
Medical oncology regimens submitted through portal
Provider satisfaction with Evolent's support
Oncology program outcomes published in Journal of Clinical Pathways
Cancer diseases covered by high-value clinical pathways
Increasing adherence to high-value clinical pathways in oncology
30%+ increase in pathway adherence
Reducing low-value oncology regimens through collegial provider engagement
20% reduction in low-value regimens
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Evolent's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.